Arginine metabolism and deprivation in cancer therapy

Biomed Pharmacother. 2019 Oct:118:109210. doi: 10.1016/j.biopha.2019.109210. Epub 2019 Jul 19.

Abstract

Certain cancer cells with nutrient auxotrophy and have a much higher nutrient demand compared with normal human cells. Arginine as a versatile amino acid, has multiple biological functions in metabolic and signaling pathways. Depletion of this amino acid by arginine depletor is generally well tolerated and has become a targeted therapy for arginine auxotrophic cancers. However, the modulatory eff ;ect of arginine on cancer cells is very complicated and still controversial. Therefore, this article focuses on arginine metabolism and depletion therapy in cancer treatment to provide systemical review on this issue.

Keywords: Arginine; Cancer; Deprivation; Metabolism.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Arginine / metabolism*
  • Clinical Trials as Topic
  • Drug Discovery
  • Drug Evaluation, Preclinical
  • Humans
  • Hydrolases / adverse effects
  • Hydrolases / pharmacology
  • Hydrolases / therapeutic use*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / pharmacology
  • Polyethylene Glycols / therapeutic use*

Substances

  • Antineoplastic Agents
  • Polyethylene Glycols
  • Arginine
  • Hydrolases
  • ADI PEG20